Category: Cold Chain Spotlight

  • Reflect Scientific awarded patent for low temperature bulk shipping system

    Reflect Scientific, Inc. has been awarded a patent for a cryogenic modular shipping unit that can uniformly maintain its payload at temperatures as low as -90°C, making it suited for cold chain management of biologics including Covid-19 vaccines. The cryogenic system provides a capability of short or long duration bulk shipping and may also be […]

  • UNICEF to stockpile more than a half billion syringes by year end

    In anticipation of forthcoming Covid-19 vaccine approvals, the United Nations Children’s Fund (UNICEF) announced plans to stockpile 520 million syringes in its warehouses, part of a larger plan to have a billion syringes ready for use through 2021 in order to guarantee initial supply and help ensure that syringes arrive before vaccines are distributed. To […]

  • Drone deliveries of cold chain medicines begin in rural North Carolina

    Volansi, Inc., an on-demand aerial delivery service for time-critical shipments, has begun delivering cold chain medicines from Merck’s Wilson, N.C. manufacturing site to Vidant Healthplex-Wilson, a medical center operated by Vidant Health and serving rural portions of the state. Initial flights in the project resulted in the first drone delivery of temperature-controlled medicines within the […]

  • BioLife division gets $2.7m cold chain and storage contract for Covid-19 vaccines

    BioLife Solutions, Inc.’s recently acquired SciSafe division has been awarded a two-year contract estimated at $2.7 million from an unnamed ‘large pharmaceutical company’ for cold chain management and storage of Covid-19 vaccines. SciSafe, a provider of biological materials storage founded in 2010, maintains four cGMP-compliant facilities located in New Jersey, Massachusetts and Utah, with an expansion plan focused on […]

  • IQVIA: Biosimilars on track to reduce drug costs by $100b over next five years

    Biosimilar medicine availability and use are growing and on track to reduce drug costs by $100 billion over the next five years, according to a new report from the IQVIA Institute for Human Data Science. The development and approvals of biosimilars have been accelerating in the U.S. over the past two years, bringing a total […]

  • Mapi Pharma earmarks space for vaccine production facility

    Mapi Pharma Ltd., a late clinical stage biopharmaceutical company, plans to dedicate production capacity at its Jerusalem Har-Hotzim manufacturing facility for upcoming Covid-19 vaccines destined for Israel, the European Union and other potential locations. The company’s GMP facility is audited by the Israeli Ministry of Health, with approvals that are mutually recognized by the EU, […]

  • ‘Green’ new reefer trailer being tested for pollution-free shipping of biologics

    Reflect Scientific, Inc., a provider of products and services for the biotechnology, pharmaceutical and transportation industries, has been testing an electric-powered heavy-duty truck to potentially replace the diesel-powered tractor trailers that currently are in use for the movement of goods requiring controlled temperatures. Cryometrix 53-foot reefer trailer (Credit: Reflect Scientific, Inc. via GlobeNewswire) The Cryometrix […]

  • International logistics firm takes steps to build supply chain visibility and resiliency

    Chicago-based project44, a supply chain visibility and logistics service, announced a series of new capabilities offering enhanced collaboration, automation and predictive insights to help shippers drive performance, productivity and customer experience. In the pharmaceutical and biotech sectors the company provides a range of temperature control services, predictive tracking, secure data flow, collaboration, rapid carrier onboarding and accelerated ROI, […]

  • New line of thermal packaging hits the market

    Packaging Technology Group, Inc., a provider of thermal packaging for the biopharmaceutical and life sciences sector, has initiated a new line of off-the-shelf pre-qualified shippers, including an eco-friendly alternative. As pharmaceutical manufacturers race to respond to the global health crisis with a vaccine, the need to protect any potential vaccine’s temperature tolerance remains a priority. […]

  • J&J and Europe agree on Janssen Covid-19 vaccine candidate, subject to regulatory okay

    The European Commission (EC), acting on behalf of the European Union (EU) member states, has approved an advance purchase agreement in which the Janssen Pharmaceutical Companies will supply 200 million doses of its Covid-19 vaccine candidate following approval or authorization from regulators. The member states also have the option to secure up to 200 million […]

  • Carrier cold chain initiative targets growing vaccine demand

    Carrier Global Corp., a provider of cold chain assets and intelligence, has launched a program designed to help meet the rapidly evolving cold chain demands for advanced refrigeration technology to protect medicines, vaccines and food. “The times we live in have increased the importance of cold chain resiliency and accelerated the need for more connected […]

  • Prioritizing cold chain sustainability

    According to results from a newly released cold chain sustainability survey, the biopharma industry is increasing its pace to prioritize sustainability in business and operational strategies. Nearly half of all respondents in the survey, produced by Pelican BioThermal, indicate that their existing practice had always factored sustainability into cold chain purchasing decisions. Overall, the survey […]